Ensembl ID ENSG00000160201 Gene ID 7307 Accession 12453
Gene Symbol U2AF1 Alias RN;FP793;U2AF35;U2AFBP;RNU2AF1 Full Name U2 small nuclear RNA auxiliary factor 1
Position 21 : 43092956 - 43107570 Length 14615 bases Strand Minus strand
Status Confidence Main interacting RNAsmRNARBP type Canonical_RBPs
Summary This gene belongs to the splicing factor SR family of genes. U2 auxiliary factor, comprising a large and a small subunit, is a non-snRNP protein required for the binding of U2 snRNP to the pre-mRNA branch site. This gene encodes the small subunit which plays a critical role in both constitutive and enhancer-dependent RNA splicing by directly mediating interactions between the large subunit and proteins bound to the enhancers. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

ENSG00000160201 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000160201 U2AF1 1.59 3.92e-19 KIRC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000160201 U2AF1 pancreatic cancer 11830556
ENSG00000160201 U2AF1 cancer 22158538
ENSG00000160201 U2AF1 AML 22823977
ENSG00000160201 U2AF1 acute myeloid leukemia (AML) 23029227
ENSG00000160201 U2AF1 tumors 23280334
ENSG00000160201 U2AF1 cancers 23300180
ENSG00000160201 U2AF1 AML 23645565
ENSG00000160201 U2AF1 tumor 23775717
ENSG00000160201 U2AF1 AML 24498085
ENSG00000160201 U2AF1 pancreatic cancer 25174478
ENSG00000160201 U2AF1 AML 25220401
ENSG00000160201 U2AF1 cancers 25271374
ENSG00000160201 U2AF1 AMLs 25331116
ENSG00000160201 U2AF1 GBM 25348067
ENSG00000160201 U2AF1 acute myeloid leukemia (AML) 25412851
ENSG00000160201 U2AF1 AML 25550361
ENSG00000160201 U2AF1 cancers 25901584
ENSG00000160201 U2AF1 AML 26115659
ENSG00000160201 U2AF1 Wilms tumor 26315090
ENSG00000160201 U2AF1 tumors 26406946
ENSG00000160201 U2AF1 cancer 26728853
ENSG00000160201 U2AF1 cancer 26732650
ENSG00000160201 U2AF1 cancer 26798410
ENSG00000160201 U2AF1 AML 26812887
ENSG00000160201 U2AF1 cancers 26886259
ENSG00000160201 U2AF1 cancers 27184077
ENSG00000160201 U2AF1 AML 27389053
ENSG00000160201 U2AF1 cancer 27492256
ENSG00000160201 U2AF1 cancer 27602765
ENSG00000160201 U2AF1 Tumors 27776121
ENSG00000160201 U2AF1 cancers 27857975
ENSG00000160201 U2AF1 AML 27983727
ENSG00000160201 U2AF1 AML 28067246
ENSG00000160201 U2AF1 AML 28419183
ENSG00000160201 U2AF1 cancers 28436936
ENSG00000160201 U2AF1 AML 28452111
ENSG00000160201 U2AF1 cancer 28850223
ENSG00000160201 U2AF1 cancer 28893951
ENSG00000160201 U2AF1 cancer 29023197
ENSG00000160201 U2AF1 Cancer 29321554
ENSG00000160201 U2AF1 AML 29343972
ENSG00000160201 U2AF1 cancer 29457796
ENSG00000160201 U2AF1 lung cancer 29991672
ENSG00000160201 U2AF1 AML 30004607
ENSG00000160201 U2AF1 Cancer 30054334
ENSG00000160201 U2AF1 AML 30142822
ENSG00000160201 U2AF1 cancer 30194306
ENSG00000160201 U2AF1 cancers 30295127
ENSG00000160201 U2AF1 cancers 30322915
ENSG00000160201 U2AF1 cancer 30693020
ENSG00000160201 U2AF1 AML 30704227
ENSG00000160201 U2AF1 AML 30813354
ENSG00000160201 U2AF1 cancer 30842218
ENSG00000160201 U2AF1 AML 31011167
ENSG00000160201 U2AF1 tumor 31024753
ENSG00000160201 U2AF1 AML 31124956
ENSG00000160201 U2AF1 cancer 31144421
ENSG00000160201 U2AF1 Cancer 31303761
ENSG00000160201 U2AF1 AML 31334570
ENSG00000160201 U2AF1 tumor 31426461
ENSG00000160201 U2AF1 AML 31467542
ENSG00000160201 U2AF1 tumors 31561558
ENSG00000160201 U2AF1 cancer 31634348
ENSG00000160201 U2AF1 cancers 31666932
ENSG00000160201 U2AF1 acute myeloid leukemia (AML) 31766606
ENSG00000160201 U2AF1 tumor 31836708
ENSG00000160201 U2AF1 AML 31921515
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000160201 U2AF1 acute myeloid leukemia missense_variant 2.404% (129/5366) 10 entries
ENSG00000160201 U2AF1 myelodysplastic syndrome missense_variant 7.183% (228/3174) 20 entries
ENSG00000160201 U2AF1 acute myeloid leukemia sequence_alteration 2.404% (129/5366) 7 entries
ENSG00000160201 U2AF1 chronic myelomonocytic leukemia missense_variant 8.775% (53/604) 10 entries
ENSG00000160201 U2AF1 hemangioblastoma sequence_alteration 45.71% (16/35) 1 entry
ENSG00000160201 U2AF1 myelodysplastic syndrome frameshift_variant 7.183% (228/3174) 3 entries
ENSG00000160201 U2AF1 myelodysplastic syndrome sequence_alteration 7.183% (228/3174) 11 entries
ENSG00000160201 U2AF1 acute myeloid leukemia amino_acid_insertion 2.404% (129/5366) 1 entry
ENSG00000160201 U2AF1 chronic myelomonocytic leukemia sequence_alteration 8.775% (53/604) 7 entries
ENSG00000160201 U2AF1 lymphoid neoplasm sequence_alteration 0.9967% (3/301) 1 entry
ENSG00000160201 U2AF1 gastric intestinal type adenocarcinoma missense_variant 2.353% (2/85) 2 entries
ENSG00000160201 U2AF1 hairy cell leukemia missense_variant 4.124% (4/97) 2 entries
ENSG00000160201 U2AF1 bronchoalveolar adenocarcinoma missense_variant 9.091% (2/22) 1 entry
ENSG00000160201 U2AF1 breast ductal adenocarcinoma missense_variant 0.3752% (6/1599) 1 entry
ENSG00000160201 U2AF1 Sinonasal Undifferentiated Carcinoma missense_variant 16.67% (2/12) 2 entries
ENSG00000160201 U2AF1 Myelodysplastic/Myeloproliferative Neoplasm missense_variant 3.03% (2/66) 2 entries
ENSG00000160201 U2AF1 colorectal adenocarcinoma sequence_alteration 2.182% (34/1558) 1 entry
ENSG00000160201 U2AF1 cecum adenocarcinoma sequence_alteration 2.281% (6/263) 2 entries
ENSG00000160201 U2AF1 colorectal adenocarcinoma conservative_inframe_deletion 2.182% (34/1558) 1 entry
ENSG00000160201 U2AF1 Borderline Ovarian Mucinous Tumor missense_variant 22.22% (2/9) 2 entries
ENSG00000160201 U2AF1 acute lymphoblastic leukemia sequence_alteration 0.3384% (2/591) 1 entry
ENSG00000160201 U2AF1 thyroid carcinoma sequence_alteration 0.324% (3/926) 1 entry
ENSG00000160201 U2AF1 esophageal squamous cell carcinoma missense_variant 0.292% (2/685) 1 entry
ENSG00000160201 U2AF1 pancreatic ductal adenocarcinoma missense_variant 1.171% (20/1708) 3 entries
ENSG00000160201 U2AF1 Endometrial Endometrioid Adenocarcinoma sequence_alteration 1.7% (11/647) 1 entry
ENSG00000160201 U2AF1 skin melanoma missense_variant 0.431% (5/1160) 2 entries
ENSG00000160201 U2AF1 bronchoalveolar adenocarcinoma sequence_alteration 9.091% (2/22) 1 entry
ENSG00000160201 U2AF1 colorectal adenocarcinoma missense_variant 2.182% (34/1558) 2 entries
ENSG00000160201 U2AF1 Mast Cell Neoplasm missense_variant 7.895% (3/38) 2 entries
ENSG00000160201 U2AF1 lung adenocarcinoma sequence_alteration 2.128% (54/2538) 6 entries
ENSG00000160201 U2AF1 bladder transitional cell carcinoma missense_variant 2.397% (11/459) 4 entries
ENSG00000160201 U2AF1 chronic myelogenous leukemia missense_variant 3.604% (4/111) 3 entries
ENSG00000160201 U2AF1 Ampulla of Vater Carcinoma missense_variant 1.523% (3/197) 1 entry
ENSG00000160201 U2AF1 Endometrial Endometrioid Adenocarcinoma missense_variant 1.7% (11/647) 1 entry
ENSG00000160201 U2AF1 Gallbladder Adenocarcinoma missense_variant 2.158% (3/139) 2 entries
ENSG00000160201 U2AF1 lung adenocarcinoma missense_variant 2.128% (54/2538) 7 entries
ENSG00000160201 U2AF1 Ampulla of Vater Carcinoma sequence_alteration 1.523% (3/197) 1 entry
ENSG00000160201 U2AF1 T-cell acute lymphoblastic leukemia missense_variant 0.8876% (6/676) 2 entries
ENSG00000160201 U2AF1 Uterine Carcinosarcoma sequence_alteration 2.703% (4/148) 1 entry
ENSG00000160201 U2AF1 esophageal adenocarcinoma sequence_alteration 1.28% (7/547) 1 entry
ENSG00000160201 U2AF1 colon adenocarcinoma sequence_alteration 1.595% (20/1254) 3 entries
ENSG00000160201 U2AF1 Gallbladder Adenocarcinoma sequence_alteration 2.158% (3/139) 1 entry
ENSG00000160201 U2AF1 bladder transitional cell carcinoma sequence_alteration 2.397% (11/459) 4 entries
ENSG00000160201 U2AF1 colon adenocarcinoma stop_gained 1.595% (20/1254) 1 entry
ENSG00000160201 U2AF1 acute lymphoblastic leukemia missense_variant 0.3384% (2/591) 1 entry
ENSG00000160201 U2AF1 cervical adenocarcinoma missense_variant 50.0% (2/4) 1 entry
ENSG00000160201 U2AF1 chronic myelomonocytic leukemia amino_acid_insertion 8.775% (53/604) 1 entry
ENSG00000160201 U2AF1 Mast Cell Neoplasm sequence_alteration 7.895% (3/38) 2 entries
ENSG00000160201 U2AF1 Uterine Carcinosarcoma missense_variant 2.703% (4/148) 1 entry
ENSG00000160201 U2AF1 gastric intestinal type adenocarcinoma sequence_alteration 2.353% (2/85) 2 entries
ENSG00000160201 U2AF1 skin melanoma sequence_alteration 0.431% (5/1160) 2 entries
ENSG00000160201 U2AF1 hepatocellular carcinoma sequence_alteration 0.293% (3/1024) 1 entry
ENSG00000160201 U2AF1 prostate adenocarcinoma sequence_alteration 0.3713% (9/2424) 1 entry
ENSG00000160201 U2AF1 hairy cell leukemia sequence_alteration 4.124% (4/97) 2 entries
ENSG00000160201 U2AF1 pancreatic ductal adenocarcinoma sequence_alteration 1.171% (20/1708) 3 entries
ENSG00000160201 U2AF1 rectal adenocarcinoma sequence_alteration 0.9158% (5/546) 1 entry
ENSG00000160201 U2AF1 non-small cell lung carcinoma missense_variant 0.9132% (2/219) 1 entry
ENSG00000160201 U2AF1 squamous cell lung carcinoma sequence_alteration 0.4292% (4/932) 1 entry
ENSG00000160201 U2AF1 diffuse large B-cell lymphoma missense_variant 0.4024% (2/497) 2 entries
ENSG00000160201 U2AF1 thyroid carcinoma missense_variant 0.324% (3/926) 1 entry
ENSG00000160201 U2AF1 acute myeloid leukemia transcript_ablation 2.404% (129/5366) 1 entry
ENSG00000160201 U2AF1 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma missense_variant 0.7576% (2/264) 2 entries
ENSG00000160201 U2AF1 cecum adenocarcinoma missense_variant 2.281% (6/263) 2 entries
ENSG00000160201 U2AF1 prostate carcinoma sequence_alteration 0.7026% (3/427) 1 entry
ENSG00000160201 U2AF1 colon adenocarcinoma missense_variant 1.595% (20/1254) 3 entries
ENSG00000160201 U2AF1 squamous cell lung carcinoma missense_variant 0.4292% (4/932) 1 entry
ENSG00000160201 U2AF1 T-cell acute lymphoblastic leukemia sequence_alteration 0.8876% (6/676) 2 entries
ENSG00000160201 U2AF1 rectal adenocarcinoma missense_variant 0.9158% (5/546) 2 entries
ENSG00000160201 U2AF1 colon adenocarcinoma conservative_inframe_deletion 1.595% (20/1254) 2 entries
ENSG00000160201 U2AF1 urothelial carcinoma sequence_alteration 1.163% (1/86) 1 entry
ENSG00000160201 U2AF1 squamous cell lung carcinoma stop_lost 0.4292% (4/932) 1 entry
ENSG00000160201 U2AF1 prostate adenocarcinoma frameshift_variant 0.3713% (9/2424) 1 entry
ENSG00000160201 U2AF1 Tonsillar Squamous Cell Carcinoma sequence_alteration 11.11% (1/9) 1 entry
ENSG00000160201 U2AF1 kidney Wilms tumor missense_variant 0.3125% (1/320) 1 entry
ENSG00000160201 U2AF1 B-cell neoplasm sequence_alteration 5.556% (1/18) 1 entry
ENSG00000160201 U2AF1 Mixed Lobular and Ductal Breast Carcinoma sequence_alteration 1.562% (1/64) 1 entry
ENSG00000160201 U2AF1 Tonsillar Squamous Cell Carcinoma missense_variant 11.11% (1/9) 1 entry
ENSG00000160201 U2AF1 urothelial carcinoma missense_variant 1.163% (1/86) 1 entry
ENSG00000160201 U2AF1 undifferentiated pleomorphic sarcoma missense_variant 1.613% (1/62) 1 entry
ENSG00000160201 U2AF1 lung adenocarcinoma stop_gained 2.128% (54/2538) 1 entry
ENSG00000160201 U2AF1 desmoplastic small round cell tumor missense_variant 4.545% (1/22) 1 entry
ENSG00000160201 U2AF1 small intestinal adenocarcinoma missense_variant 4.762% (1/21) 1 entry
ENSG00000160201 U2AF1 colorectal adenocarcinoma amino_acid_insertion 2.182% (34/1558) 1 entry
ENSG00000160201 U2AF1 chronic myelogenous leukemia sequence_alteration 3.604% (4/111) 1 entry
ENSG00000160201 U2AF1 basal cell carcinoma missense_variant 1.471% (1/68) 1 entry
ENSG00000160201 U2AF1 Intimal Sarcoma missense_variant 12.5% (1/8) 1 entry
ENSG00000160201 U2AF1 Chronic Eosinophilic Leukemia, Not Otherwise Specified sequence_alteration 33.33% (1/3) 1 entry
ENSG00000160201 U2AF1 B-cell acute lymphoblastic leukemia missense_variant 0.885% (1/113) 1 entry
ENSG00000160201 U2AF1 Mantle cell lymphoma sequence_alteration 1.493% (1/67) 1 entry
ENSG00000160201 U2AF1 nasal cavity and paranasal sinus carcinoma missense_variant 4.348% (1/23) 1 entry
ENSG00000160201 U2AF1 adenosquamous lung carcinoma sequence_alteration 4.545% (1/22) 1 entry
ENSG00000160201 U2AF1 prostate carcinoma missense_variant 0.7026% (3/427) 1 entry
ENSG00000160201 U2AF1 hepatocellular carcinoma missense_variant 0.293% (3/1024) 1 entry
ENSG00000160201 U2AF1 Chronic Neutrophilic Leukemia missense_variant 25.0% (1/4) 1 entry
ENSG00000160201 U2AF1 diffuse large B-cell lymphoma sequence_alteration 0.4024% (2/497) 1 entry
ENSG00000160201 U2AF1 Mantle cell lymphoma missense_variant 1.493% (1/67) 1 entry
ENSG00000160201 U2AF1 Mixed Lobular and Ductal Breast Carcinoma missense_variant 1.562% (1/64) 1 entry
ENSG00000160201 U2AF1 Chronic Eosinophilic Leukemia, Not Otherwise Specified missense_variant 33.33% (1/3) 1 entry
ENSG00000160201 U2AF1 B-cell neoplasm missense_variant 5.556% (1/18) 1 entry
ENSG00000160201 U2AF1 Thymic Squamous Cell Carcinoma missense_variant 5.556% (1/18) 1 entry
ENSG00000160201 U2AF1 non-small cell lung carcinoma sequence_alteration 0.9132% (2/219) 1 entry
ENSG00000160201 U2AF1 Merkel cell skin cancer sequence_alteration 1.064% (1/94) 1 entry
ENSG00000160201 U2AF1 colorectal adenocarcinoma frameshift_variant 2.182% (34/1558) 1 entry
ENSG00000160201 U2AF1 breast carcinoma sequence_alteration 0.1252% (2/1598) 1 entry
ENSG00000160201 U2AF1 central nervous system primitive neuroectodermal neoplasm missense_variant 0.2232% (1/448) 1 entry
ENSG00000160201 U2AF1 Borderline Ovarian Mucinous Tumor sequence_alteration 22.22% (2/9) 1 entry
ENSG00000160201 U2AF1 multiple myeloma missense_variant 0.7634% (1/131) 1 entry
ENSG00000160201 U2AF1 clear cell renal carcinoma missense_variant 0.06901% (1/1449) 1 entry
ENSG00000160201 U2AF1 B-cell acute lymphoblastic leukemia sequence_alteration 0.885% (1/113) 1 entry
ENSG00000160201 U2AF1 colon adenocarcinoma frameshift_variant 1.595% (20/1254) 1 entry
ENSG00000160201 U2AF1 multiple myeloma sequence_alteration 0.7634% (1/131) 1 entry
ENSG00000160201 U2AF1 Peritoneal Mesothelioma missense_variant 5.556% (1/18) 1 entry
ENSG00000160201 U2AF1 lymphoid neoplasm missense_variant 0.9967% (3/301) 1 entry
ENSG00000160201 U2AF1 Merkel cell skin cancer missense_variant 1.064% (1/94) 1 entry
ENSG00000160201 U2AF1 anaplastic astrocytoma missense_variant 0.7576% (1/132) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000160201 U2AF1 MESO 0.024 high
ENSG00000160201 U2AF1 SARC 0.013 high
ENSG00000160201 U2AF1 PAAD 0.00085 low
ENSG00000160201 U2AF1 UCEC 0.017 high
ENSG00000160201 U2AF1 ACC 0.0021 high
ENSG00000160201 U2AF1 LGG 0.045 low
ENSG00000160201 U2AF1 LUSC 0.0044 low
ENSG00000160201 U2AF1 READ 0.0093 low
ENSG00000160201 U2AF1 KICH 0.049 high
ENSG00000160201 U2AF1 LUAD 0.0032 low
ENSG00000160201 U2AF1 COAD 0.016 high
ENSG00000160201 U2AF1 OV 0.0098 low
ENSG00000160201 U2AF1 DLBC 0.016 low
ENSG00000160201 U2AF1 KIRC 0.00013 high
ENSG00000160201 U2AF1 PRAD 0.027 high
ENSG00000160201 U2AF1 TGCT 0.013 low
ENSG00000160201 U2AF1 BLCA 0.013 low
ENSG00000160201 U2AF1 LAML 0.045 low
ENSG00000160201 U2AF1 SKCM 0.019 low
ENSG00000160201 U2AF1 LIHC 0.021 low
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000160201 U2AF1 LAML Amp 3.675883 0.103872 1.137394 0.068063
ENSG00000160201 U2AF1 READ Del 0.652583 0.070864 0.451652 0.418182
ENSG00000160201 U2AF1 STAD Del 1.257549 0.068740 0.376835 0.442177